4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-017036
CEO and CFO bought 8,000 shares at $7.13 ($57,040)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-16 | Purchase | +8,000 | $7.13 | $57,040 | 2,683,886 | D |
| Open-market purchases · 8,000 sh · avg $7.13 · $57,040 | |||||||
Loading xslF345X03/ownership.xml…